Publicaciones

Consulta nuestras publicaciones

PUBLICACIONES

Desde el año 2007 GENVIP ha publicado más de 430 publicaciones

Mostrando 0 de
0 publicaciones
highlight
Resetear todo

Año

Borrar

Journal

Borrar
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filtros aplicados:
Tag
close icon
Ordenar por
FEBRILE CHILDREN WITH COMORBIDITIES AT THE EMERGENCY DEPARTMENT - A MULTICENTRE OBSERVATIONAL STUDY
Borensztajn DM, Hagedoorn NN, Carrol ED, von Both U, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Tsolia M, van der Velden FJS, Vermont C, Zavadska D, Zenz W, Zachariasse JM, Moll HA
Journal:
Eur J Pediatr
Publicación independiente
Factor de impacto:
3.860
Q1
Year:
2022
Doi:
https://doi.org/10.1007/s00431-022-04552-2
RSV PREVENTION IN ALL INFANTS: WHICH IS THE MOST PREFERABLE STRATEGY?
Esposito S, Abu Raya B, Baraldi E, Flanagan K, Martinon Torres F, Tsolia M, Zielen S
Journal:
Front Immunol
Publicación independiente
Factor de impacto:
8.876
Q1
Year:
2022
Doi:
https://doi.org/10.3389/fimmu.2022.880368
RISK ANALYSIS BY AGE ON THE BURDEN OF MENINGOCOCCAL DISEASE IN SPAIN
Rivero-Calle I, Raguindin PF, Pardo-Seco J, Martinon-Torres F
Journal:
Vaccines
Publicación independiente
Factor de impacto:
4.961
Q2
Year:
2022
Doi:
https://doi.org/10.3390/vaccines10040592
MENINGOCOCCAL B VACCINE EFFECTIVENESS
Banzhoff A, Martinón-Torres F
Journal:
J Pediatr
Publicación independiente
Factor de impacto:
6.314
Q1
Year:
2022
Doi:
https://doi.org/10.1016/j.jpeds.2021.12.074
GLOBAL, REGIONAL, AND NATIONAL DISEASE BURDEN ESTIMATES OF ACUTE LOWER RESPIRATORY INFECTIONS DUE TO RESPIRATORY SYNCYTIAL VIRUS IN CHILDREN YOUNGER THAN 5 YEARS IN 2019: A SYSTEMATIC ANALYSIS
Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H, Pariente AB, Bardach D, Bassat Q, Casalegno JS, Chakhunashvili G, Crawford N, Danilenko D, Do LAH, Echavarria M, Gentile A, Gordon A, Heikkinen T, Huang QS, Jullien S, Krishnan A, Lopez EL, Markić J, Mira-Iglesias A, Moore HC, Moyes J, Mwananyanda L, Nokes DJ, Noordeen F, Obodai E, Palani N, Romero C, Salimi V, Satav A, Seo E, Shchomak Z, Singleton R, Stolyarov K, Stoszek SK, von Gottberg A, Wurzel D, Yoshida LM, Yung CF, Zar HJ; Respiratory Virus Global Epidemiology Network, Nair H; RESCEU investigators (Martinón-Torres F)
Journal:
Lancet
Publicación independiente
Factor de impacto:
202.710
Q1
Year:
2022
Doi:
¿Dónde se esconde el virus respiratorio sincitial?
Martinón-Torres F, González-Barcala FJ
Journal:
Arch Bronconeumol
Publicación independiente
Factor de impacto:
6.333
Q1
Year:
2022
Doi:
https://doi.org/10.1016/j.arbres.2021.06.022
A TOOL FOR EARLY ESTIMATION OF INFLUENZA VACCINATION COVERAGE IN SPANISH GENERAL POPULATION AND HEALTHCARE WORKERS IN THE 2018-19 SEASON: THE GRIPÓMETRO
Díez-Domingo J, Redondo Margüello E, Ortiz de Lejarazu Leonardo R, Gil de Miguel Á, Guillén Ortega JM, Rincón Mora J, Martinón-Torres F
Journal:
BMC Public Health
Publicación independiente
Factor de impacto:
4.135
Q2
Year:
2022
Doi:
https://doi.org/10.1186/s12889-022-13193-x
WHOOPING COUGH: THE VISIBLE ENEMY
González-Barcala FJ, Villar-Álvarez F, Martinón-Torres F
Journal:
Arch Bronconeumol
Publicación independiente
Factor de impacto:
6.333
Q1
Year:
2022
Doi:
https://doi.org/10.1016/j.arbres.2021.06.008
ROLE AND DIAGNOSTIC PERFORMANCE OF HOST EPIGENOME IN RESPIRATORY MORBIDITY AFTER RSV INFECTION: THE EPIRESVI STUDY.
Pischedda S, Rivero-Calle I, Gómez-Carballa A, Cebey-López M, Barral-Arca R, Gómez-Rial J, Pardo-Seco J, Curras-Tuala MJ, Viz-Lasheras S, Bello X, Crujeiras AB, Diaz-Lagares A, González-López MT, Martinón-Torres F, Salas A; GENDRES consortium
Journal:
Front Immunol
Publicación independiente
Factor de impacto:
8.786
Q1
Year:
2022
Doi:
https://doi.org/10.3389/fimmu.2022.875691
EVALUATION OF BNT162B2 VACCINE EFFECTIVENESS IN GALICIA, NORTHWEST SPAIN
Pardo-Seco J, Mallah N, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, Durán-Parrondo C, Rodríguez-Tenreiro C, Rivero-Calle I, Gómez-Carballa A, Salas A, Martinón-Torres F
Journal:
Int J Environ Res Public Health
Publicación independiente
Factor de impacto:
3.390
Q2
Year:
2022
Doi:
https://doi.org/10.3390/ijerph19074039
¿Dónde se esconde el virus respiratorio sincitial?
Martinón-Torres F, González-Barcala FJ
Journal:
Arch Bronconeumol
Publicación independiente
Factor de impacto:
4.872
Q2
Year:
2022
Doi:
https://doi.org/10.1016/j.arbres.2021.06.007
YEAR-TO-YEAR VARIATION IN ATTACK RATES COULD RESULT IN UNDERPOWERED RESPIRATORY SYNCYTIAL VIRUS VACCINE EFFICACY TRIALS
Billard MN, Wildenbeest J, Bont LJ, Nair H, McCracken JP, Oude Rengerink K; RESCEU Investigators (Martinón-Torres F)
Journal:
J Clin Epidemiol
Publicación independiente
Factor de impacto:
6.437
Q1
Year:
2022
Doi:
COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE PREVENTION STRATEGIES: MATERNAL VACCINE VERSUS SEASONAL OR YEAR-ROUND MONOCLONAL ANTIBODY PROGRAM IN NORWEGIAN CHILDREN
Li X, Bilcke J, Vázquez Fernández L, Bont L, Willem L, Wisløff T, Jit M, Beutels P; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators. (martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Factor de impacto:
5.226
Q1
Year:
2022
Doi:
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II TRIAL TO EXPLORE THE EFFECTS OF A GABAA-Α5 NAM (BASMISANIL) ON INTELLECTUAL DISABILITY ASSOCIATED WITH DOWN SYNDROME
Goeldner C, Kishnani PS, Skotko BG, Casero JL, Hipp JF, Derks M, Hernandez MC, Khwaja O, Lennon-Chrimes S, Noeldeke J, Pellicer S, Squassante L, Visootsak J, Wandel C, Fontoura P, d'Ardhuy XL; Clematis Study Group (Martinón-Torres F)
Journal:
J Neurodev Disord
Publicación independiente
Factor de impacto:
4.025
Q2
Year:
2022
Doi:
PERFORMANCE ASSESSMENT OF A RAPID MOLECULAR RESPIRATORY SYNCYTIAL VIRUS POINT-OF-CARE TEST: A PROSPECTIVE COMMUNITY STUDY IN OLDER ADULTS
Zuurbier RP, Korsten K, Verheij TJM, Butler C, Adriaenssens N, Coenen S, Gruselle O, Vantomme V, van Houten MA, Bont LJ, Wildenbeest JG; REspiratory Syncytial Virus Consortium in EUrope (RESCEU) Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Factor de impacto:
5.226
Q1
Year:
2022
Doi:
RAPID VIRAL TESTING AND ANTIBIOTIC PRESCRIPTION IN FEBRILE CHILDREN WITH RESPIRATORY SYMPTOMS VISITING EMERGENCY DEPARTMENTS IN EUROPE
Tan CD, Hagedoorn NN, Dewez JE, Borensztajn DM, von Both U, Carrol ED, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Strle F, Tsolia M, Vermont CL, Yeung S, Zachariasse JM, Zenz W, Zavadska D, Moll HA; PERFORM Consortium
Journal:
Pediatr Infect Dis J
Publicación independiente
Factor de impacto:
2.129
Q4
Year:
2022
Doi:
https://doi.org/10.1097/INF.0000000000003326
Pediatric vaccination against COVID-19 and despite COVID-19
Martinón-Torres F
Journal:
An Pediatr (Engl Ed)
Publicación independiente
Factor de impacto:
1.500
Q4
Year:
2022
Doi:
https://doi.org/10.1016/j.anpede.2021.11.001
A SYSTEMATIC REVIEW OF EUROPEAN CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS
Reeves RM, van Wijhe M, Lehtonen T, Stona L, Teirlinck AC, Vazquez Fernandez L, Li Y, Osei-Yeboah R, Fischer TK, Heikkinen T, van Boven M, Bøås H, Donà D, Barbieri E, Campbell H; RESCEU Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Factor de impacto:
5.022
Q1
Year:
2022
Doi:
EQUITY IN VACCINATION POLICIES TO OVERCOME SOCIAL DEPRIVATION AS A RISK FACTOR FOR INVASIVE MENINGOCOCCAL DISEASE.
Taha MK, Martinon-Torres F, Köllges R, Bonanni P, Safadi MAP, Booy R, Smith V, Garcia S, Bekkat-Berkani R, Abitbol V
Journal:
Expert Rev Vaccines
Publicación independiente
Factor de impacto:
5.217
Q2
Year:
2022
Doi:
https://doi.org/10.1080/14760584.2022.2052048
COVIDPHY: A TOOL FOR PHYLOGEOGRAPHIC ANALYSIS OF SARS-COV-2 VARIATION
Bello X, Pardo-Seco J, Gómez-Carballa A, Weissensteiner H, Martinón-Torres F, Salas A
Journal:
Environ Res
Publicación independiente
Factor de impacto:
6.498
Q1
Year:
2022
Doi:
https://doi.org/10.1016/j.envres.2021.111909
CHARACTERISTICS AND MANAGEMENT OF ADOLESCENTS ATTENDING THE ED WITH FEVER: A PROSPECTIVE MULTICENTRE STUDY
Borensztajn D, Hagedoorn NN, Carrol E, von Both U, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie I, Martinon Torres F, Nijman R, Pokorn M, Rivero-Calle I, Tsolia M, Vermont C, Zavadska D, Zenz W, Zachariasse J, Moll HA; PERFORM Consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union.
Journal:
BMJ Open
Publicación independiente
Factor de impacto:
2.692
Q2
Year:
2022
Doi:
https://doi.org/10.1136/bmjopen-2021-053451
EVOLVING STRATEGIES FOR MENINGOCOCCAL VACCINATION IN EUROPE: OVERVIEW AND KEY DETERMINANTS FOR CURRENT AND FUTURE CONSIDERATIONS
Martinón-Torres F, Taha MK, Knuf M, Abbing-Karahagopian V, Pellegrini M, Bekkat-Berkani R, Abitbol V
Journal:
Pathog Glob Health
Publicación independiente
Factor de impacto:
2.894
Q2
Year:
2022
Doi:
https://doi.org/10.1080/20477724.2021.1972663
IMPROVING EMPIRIC ANTIBIOTIC PRESCRIBING IN PEDIATRIC BLOODSTREAM INFECTIONS: A POTENTIAL APPLICATION OF WEIGHTED-INCIDENCE SYNDROMIC COMBINATION ANTIBIOGRAMS (WISCA)
Cook A, Sharland M, Yau Y; PediBSI Group*, Bielicki J. (Martinón-Torres F)
Journal:
Expert Rev Anti Infect Ther.
Publicación independiente
Factor de impacto:
5.091
Q1
Year:
2022
Doi:
Vacunación pediátrica frente al COVID-19 y a pesar del COVID-19 [Pediatric vaccination against COVID-19 and despite COVID-19]
Martinón-Torres F
Journal:
An Pediatr (Barc)
Publicación independiente
Factor de impacto:
1.500
Q4
Year:
2022
Doi:
https://doi.org/10.1016/j.anpedi.2021.11.008
No se han encontrado resultados.
CASE REPORT: TWO MONOCHORIONIC TWINS WITH A CRITICALLY DIFFERENT COURSE OF PROGRESSIVE OSSEUS HETEROPLASIA
Justicia-Grande AJ, Gómez-Ríal J, Rivero-Calle I, Pischedda S, Curras-Tuala MJ, Gómez-Carballa A, Cebey-López M, Pardo-Seco J, Méndez-Gallart R, Fernández-Seara MJ, Salas A, Martinón-Torres F
Doi:
Front Pediatr
Factor de impacto:
Q1
Doi:
INTERFERON-GAMMA RELEASE ASSAYS DIFFERENTIATE BETWEEN MYCOBACTERIUM AVIUM COMPLEX AND TUBERCULOUS LYMPHADENITIS IN CHILDREN
Martínez-Planas A, Baquero-Artigao F, Santiago B, Fortuny C, Méndez-Echevarría A, Del Rosal T, Bustillo-Alonso M, Gale I, Guerrero C, Blázquez-Gamero D, Canet A, Lillo M, Calavia O, Núñez Cuadros E, Falcón-Neyra L, Soriano-Arandes A, Van Ingen J, Tebruegge M, Noguera-Julian A; Spanish Pediatric TB Research Network (pTBred) and the European NontuberculouS MycoBacterial Lymphadenitis in childrEn (ENSeMBLE) Study. (Federico Martinón Torres)
Doi:
J Pediatr
Factor de impacto:
Q1
Doi:
TREATMENT OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN
McArdle AJ, Vito O, Patel H, Seaby EG, Shah P, Wilson C, Broderick C, Nijman R, Tremoulet AH, Munblit D, Ulloa-Gutierrez R, Carter MJ, De T, Hoggart C, Whittaker E, Herberg JA, Kaforou M, Cunnington AJ, Levin M; BATS Consortium; (Federico Martinón Torres)
Doi:
N Engl J Med
Factor de impacto:
Q1
Doi:
DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR INVASIVE BACTERIAL INFECTIONS IN FEBRILE CHILDREN AT EUROPEAN EMERGENCY DEPARTMENTS: MOFICHE, A PROSPECTIVE OBSERVATIONAL STUDY
Hagedoorn NN, Borensztajn D, Nijman RG, Nieboer D, Herberg JA, Balode A, von Both U, Carrol E, Eleftheriou I, Emonts M, van der Flier M, de Groot R, Kohlmaier B, Lim E, Maconochie I, Martinón-Torres F, Pokorn M, Strle F, Tsolia M, Zavadska D, Zenz W, Levin M, Vermont C, Moll HA
Doi:
Arch Dis Child
Factor de impacto:
Q1
Doi:
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination
Schaffner, T. O.; Martinon-Torres F; Banzhoff, A; Azzari, C;De Wals, P; Marlow, R; Marshall, H; Pizza, M; Rappuoli, R; Bekkat, Berkani R.
Doi:
Swiss Medical Weekly
Factor de impacto:
Q3
Doi:
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination
Martinón-Torres F, Banzhoff A, Azzari C, De Wals P, Marlow R, Marshall H, Pizza M, Rappuoli R, Berkani RB
Doi:
J Infect
Factor de impacto:
Q1
Doi:
IDENTIFICATION OF NOVEL LOCUS ASSOCIATED WITH CORONARY ARTERY ANEURYSMS AND VALIDATION OF LOCI FOR SUSCEPTIBILITY TO KAWASAKI DISEASE
Hoggart C, Shimizu C, Galassini R, Wright VJ, Shailes H, Bellos E, Herberg JA, Pollard AJ, O'Connor D, Choi SW, Seaby EG, Menikou S, Hibberd M, Sallah N, Burgner D, Brogan P, Patel H, Kim J, Tremoulet AH, Salo E, van Stijn D, Kuijpers T, Burns JC, Levin M; International Kawasaki Disease Genetics Consortium; UK Kawasaki Disease Genetics Consortium; EUCLIDS Consortium (Martinón Torres Federico)
Doi:
Eur J Hum Genet
Factor de impacto:
Q2
Doi:
TIPICO X: REPORT OF THE 10TH INTERACTIVE INFECTIOUS DISEASE WORKSHOP ON INFECTIOUS DISEASES AND VACCINES
Rivero-Calle I, Gómez-Rial J, Bont L, Gessner BD, Kohn M, Dagan R, Payne DC, Bruni L, Pollard AJ, García-Sastre A, Faustman DL, Osterhaus A, Butler R, Giménez Sánchez F, Álvarez F, Kaforou M, Bello X, Martinón-Torres F
Doi:
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
IDENTIFICATION OF A MINIMAL 3-TRANSCRIPT SIGNATURE TO DIFFERENTIATE VIRAL FROM BACTERIAL INFECTION FROM BEST GENOME-WIDE HOST RNA BIOMARKERS: A MULTI-COHORT ANALYSIS
Gómez-Carballa A, Barral-Arca R, Cebey-López M, Bello X, Pardo-Seco J, Martinón-Torres F, Salas A
Doi:
International J Molecular Sciences
Factor de impacto:
Q1
Doi:
Vacuna antigripal trivalente de alta dosis: seguridad e inmunogenicidad
Ortiz de Lejarazu R, Martinón Torres F, Gil de Miguel A, Díez Domingo J,Redondo Marguello E
Doi:
Rev. Esp Quimioter
Factor de impacto:
Q4
Doi:
PHYLOGEOGRAPHY OF SARS-COV-2 PANDEMIC IN SPAIN: A STORY OF MULTIPLE INTRODUCTIONS, MICRO-GEOGRAPHIC STRATIFICATION, FOUNDER EFFECTS, AND SUPER-SPREADERS
Gómez-Carballa A, Bello X, Pardo-Seco J, Del Molino MLP, Martinón-Torres F, Salas A.
Zoological Research
Factor de impacto:
Q1
Doi:
EXTRAORDINARY CLAIMS REQUIRE EXTRAORDINARY EVIDENCE IN ASSERTED MTDNA BIPARENTAL INHERITANCE
Antonio Salas, Sebastian Schönherr, Hans-Jürgen Bandelt, Alberto Gómez-Carballa, Hansi Weissensteiner (Federico Martinón Torres)
Forensic Sci Int Genet
Factor de impacto:
Q1
Doi:
ROTAVIRUS AND AUTOIMMUNITY
Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F
J Infect
Factor de impacto:
Q1
Doi:
GLOBAL MOLECULAR EPIDEMIOLOGY OF RESPIRATORY SYNCYTIAL VIRUS FROM THE 2017-2018 INFORM-RSV STUDY
Tabor, David E; Fernandes, Fiona; Langedijk, Annefleur C; Wilkins, Deidre; Lebbink, Robert Jan; Tovchigrechko, Andrey; Ruzin, Alexey; Kragten-Tabatabaie, Leyla; Jin, Hong; Esser, Mark T; Bont, Louis J; Abram, Michael E (Martinón-Torres, Federico)
J. Clin. Microbiol
Factor de impacto:
Q1
Doi:
QUANTITATIVE MULTIPLEX PROFILING OF THE COMPLEMENT SYSTEM TO DIAGNOSE COMPLEMENT‐MEDIATED DISEASES
Esther Willems Laura Lorés‐Motta Andrea Zanichelli Chiara Suffritti Michiel van der Flier Renate G van der Molen Jeroen D Langereis Joris van Drongelen Lambert P van den Heuvel Elena Volokhina Nicole CAJ van de Kar Jenneke Keizer‐Garritsen Michael Levin Jethro A Herberg Federico Martinon‐Torres Hans JTC Wessels Anita de Breuk Sascha Fauser Carel B Hoyng Anneke I den Hollander Ronald de Groot Alain J van Gool Jolein Gloerich Marien I de Jonge
Clinical & Translational Immunology
Factor de impacto:
Q2
Doi:
DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR INVASIVE BACTERIAL INFECTIONS IN FEBRILE CHILDREN AT EUROPEAN EMERGENCY DEPARTMENTS: MOFICHE, A PROSPECTIVE OBSERVATIONAL STUDY
Nienke N Hagedoorn, Dorine Borensztajn, Ruud Gerard Nijman, Daan Nieboer, Jethro Adam Herberg, Anda Balode, Ulrich von Both, Enitan Carrol, Irini Eleftheriou, Marieke Emonts, Michiel van der Flier, Ronald de Groot, Benno Kohlmaier, Emma Lim, Ian Maconochie, Federico Martinón-Torres, Marko Pokorn, Franc Strle, Maria Tsolia, Dace Zavadska, Werner Zenz, Michael Levin, Clementien Vermont, Henriette A Moll
Hagedoorn NN,
Factor de impacto:
Q1
Doi:
PREVENTION OF NEW RESPIRATORY EPISODES IN CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS: AN EXPERT CONSENSUS STATEMENT
Susanna Esposito, Marcus Herbert Jones, Wojciech Feleszko, José A. Ortega Martell, Oana Falup-Pecurariu, Natalia Geppe , Federico Martinón-Torres, Kun-Ling Shen, Michael Roth and Nicola Principi
Microorganisms
Factor de impacto:
Q2
Doi:
IMMUNANTWORT AUF DIE DTPA-HBV-IPV/HIB-AUFFRISCHIMPFUNG BEI KLEINKINDERN VON MÜTTERN, DIE WÄHREND DER SCHWANGERSCHAFT MIT TDAP-IMPFSTOFF GEIMPFT WORDEN WAREN: FOLGESTUDIE EINER RANDOMISIERTEN, PLACEBOKONTROLLIERTEN STUDIE
F Martinón-Torres, SA Halperin, T Nolan, B tapiero, KP Perrett, IS de la Cueva, J García-Sicilia, Z Stranak, Vanderkooi floor, P Kosina, M Virta, JM Merino Arribas, M Miranda-Valdivieso, B Arias Novas, J Bozensky, MJ Cilleruelo Ortega, JT Ramos Amador, M Baca, Palomino E Escribano, GV Zuccotti, J Janota, PG Marchisio, L Kostanyan, N Meyer, MA Ceregido, B Cheuvart, SO Kuriyakose, N Mesaros;
Geburtshilfe Frauenheilkd
Factor de impacto:
Q2
Doi:
REPLY TO ‘‘DIAGNOSTIC CRITERIA SETS SENSITIVITY’’
Marta Vazquez-Ortiz, Laura Argiz, Adrianna Machinena, Luis Echeverria, Cristina Blasco, Ana Prieto, Sonsoles Infante, Leticia Vila, Emilio Garcia, Purificacion Gonzalez-Delgado, Sonia Vazquez-Cortes, Simona Barni, Federico Martinon-Torres
J Allergy Clin Immunol Pract
Factor de impacto:
Q1
Doi:
INCREASED SERUM LEVELS OF SCD14 AND SCD163 INDICATE A PREPONDERANT ROLE FOR MONOCYTES IN COVID-19 IMMUNOPATHOLOGY
Jose Gomez Rial, Maria Jose Curras Tuala, Irene Rivero Calle, Alberto Gomez Carballa, Miriam Cebey Lopez, Carmen Rodriguez Tenreiro, Ana Dacosta Urbieta, Carmen Rivero Velasco, Nuria Rodriguez Nunez, Rocio Trastoy Pena, Javier Rodriguez Garcia, Antonio Salas, Federico Martinon Torres
From Immunol
Factor de impacto:
Q1
Doi:
ENLACES
Servicio pediatríaGenCovidNanostringNextSeq
Aviso legalPolítica de privacidad
Genvip 2023® – Todos los derechos reservados